Collection efficiency of hematopoietic cells by apheresis after mobilization in a single centre: Analysis of the last 15 years.

IF 1.6 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2026-08-19 DOI:10.1111/vox.70347
Paula Agritzer, Paola Charry, Glòria Carbassé, Joan Cid, John-Jairo Gallego, Elena Cahuancama, María-Queralt Salas, María Suárez-Lledó, Laura Rosiñol, Francesc Fernández-Avilés, Carmen Martínez, Montserrat Rovira, Miquel Lozano
{"title":"Collection efficiency of hematopoietic cells by apheresis after mobilization in a single centre: Analysis of the last 15 years.","authors":"Paula Agritzer, Paola Charry, Glòria Carbassé, Joan Cid, John-Jairo Gallego, Elena Cahuancama, María-Queralt Salas, María Suárez-Lledó, Laura Rosiñol, Francesc Fernández-Avilés, Carmen Martínez, Montserrat Rovira, Miquel Lozano","doi":"10.1111/vox.70347","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Peripheral blood hematopoietic cells (CD34+) collection after mobilization by apheresis has largely replaced bone marrow harvest because of its safety and superior transplantation outcomes. This study aimed to evaluate temporal trends and factors influencing CD34+ collection efficiency (CE) by measuring counts before and after apheresis (CE1, in general considered a more accurate estimate of CE) over a 15-year period.</p><p><strong>Materials and methods: </strong>CD34+ cell mobilization was achieved using individualized drug regimens tailored to donor characteristics and underlying diagnosis. Apheresis procedures were carried out using Cobe Spectra, Spectra Optia and Amicus devices. Descriptive and analytical statistical analyses were performed using SPSS v29.0.</p><p><strong>Results: </strong>A total of 1435 collections from 1233 donors (658 males, 575 females; age 15-76 years) were analysed. Mean CD34+ CE1 increased significantly over time (p < 0.001). There was no statistically significant differences in CE1 between the six group of donors considered, but there were differences in CD34 counts before apheresis, number of total blood volume processed to reach the target number of CD34+ and the duration of collection. Male donors and individuals aged up to 39 years achieved the highest CE1. Pre-apheresis CD34+ count, leukocyte count, low mean corpuscular volume (MCV) and high platelet count inversely correlated with CE1.</p><p><strong>Conclusion: </strong>CD34+ CE1 improved significantly over the past 15 years, probably due to technological advancements. Several factors negatively influenced CE1, although some of them can be compensated for by changing the collection parameters in the apheresis platforms. The findings support optimization of apheresis protocols to reach maximum CD34+ CE1.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70347","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Peripheral blood hematopoietic cells (CD34+) collection after mobilization by apheresis has largely replaced bone marrow harvest because of its safety and superior transplantation outcomes. This study aimed to evaluate temporal trends and factors influencing CD34+ collection efficiency (CE) by measuring counts before and after apheresis (CE1, in general considered a more accurate estimate of CE) over a 15-year period.

Materials and methods: CD34+ cell mobilization was achieved using individualized drug regimens tailored to donor characteristics and underlying diagnosis. Apheresis procedures were carried out using Cobe Spectra, Spectra Optia and Amicus devices. Descriptive and analytical statistical analyses were performed using SPSS v29.0.

Results: A total of 1435 collections from 1233 donors (658 males, 575 females; age 15-76 years) were analysed. Mean CD34+ CE1 increased significantly over time (p < 0.001). There was no statistically significant differences in CE1 between the six group of donors considered, but there were differences in CD34 counts before apheresis, number of total blood volume processed to reach the target number of CD34+ and the duration of collection. Male donors and individuals aged up to 39 years achieved the highest CE1. Pre-apheresis CD34+ count, leukocyte count, low mean corpuscular volume (MCV) and high platelet count inversely correlated with CE1.

Conclusion: CD34+ CE1 improved significantly over the past 15 years, probably due to technological advancements. Several factors negatively influenced CE1, although some of them can be compensated for by changing the collection parameters in the apheresis platforms. The findings support optimization of apheresis protocols to reach maximum CD34+ CE1.

造血细胞单中心动员后单采收集效率:近15年分析。
背景和目的:外周血造血细胞(CD34+)的采集由于其安全性和更好的移植效果,在很大程度上取代了骨髓采集。本研究旨在通过在15年期间测量分离前后的计数(CE1,通常被认为是更准确的CE估计)来评估影响CD34+收集效率(CE)的时间趋势和因素。材料和方法:利用针对供体特征和潜在诊断量身定制的个体化药物方案实现CD34+细胞动员。采用Cobe Spectra、Spectra Optia和Amicus设备进行分离。使用SPSS v29.0进行描述性和分析性统计分析。结果:对1233例献血者1435例标本进行分析,其中男性658例,女性575例,年龄15 ~ 76岁。结论:CD34+ CE1在过去15年中显著改善,可能是由于技术进步。有几个因素对CE1有负面影响,尽管其中一些因素可以通过改变分离平台中的收集参数来补偿。研究结果支持优化单采方案以达到最大CD34+ CE1。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书